oncodesign.fr rapport :   Visitez le site

Données techniques du oncodesign.fr

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte oncodesign.fr.Actuellement, hébergé dans Italy et son fournisseur de services est IUNET BNET .

the related websites

domaine	Titre
oncology.pub	oncology.pub - the latest clinical oncology news & research
oncodesign.fr	oncodesign – biopharmaceutical company – oncology and non-oncology
codes.iarc.fr	international classification of diseases for oncology
advmodoncolres.com	advances in modern oncology research
theonc.org	home | theonc | a gated community for oncology nurses and cancer care teams

boursorama.com zonebourse.com pharmimage.fr boursier.com gazettelabo.fr lexpress.fr informationhospitaliere.com 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

-- -- fr en jp news careers contact us menu about offerings innovation model technologies investors [press release] oncodesign presents its results for the 1st half of 2018 > sharp increase in operating revenue: up 32% at €15.0 million, driven by sales growth of 58% to €9.2 million. > higher operating expenses reflecting the more rapid development of the service business and increased r&d spending for partnership and licensing activities > cash position of €9.8 million at 30 june 2018 read the press release discover innovative new therapies against cancer and serious illnesses with unmet medical needs access our innovation platform via three offerings: as a service , under a partnership or based on a licensing arrangement discover our offerings our unique, patient-centered innovation model thanks to its precision medicine platform, oncodesign is able to orient at a very early stage its research and the development of innovative therapeutic solutions for resistant and unresponsive diseases explore our model a continuum of technologies from the molecule to the patient for over 20 years, oncodesign has invested in translational research technologies to bring valuable innovation into the initial phases of the drug discovery process. discover our technologies about oncodesign read our vision management introduce our management key figures see our figures discover our sab discover our mission oncodesign in the world find us offerings service starting out from your targets or your molecules, we design and select the best drug candidates idds (integrated drug discovery services) proof of concept - pharmacology dmpk bioanalysis biobanking translational biomarkers biodecontamination / biosafety partnership use our development programs at a very early stage by entering into a long-term strategic partnership kinase inhibitor development programs technology partnership licensing license technologies, drug candidates and radiotracers from oncodesign’s portfolio kinase inhibitors in oncology, cns and inflammation technologies therapeutic areas & experimental models our innovation model etiology knowledge: identifying is a big step towards solving puzzles discovery investigation: the quest for efficacy experimentation potential: formulate new treatments technologies nanocyclix® the power and selectivity of nanocyclix® molecules applied to the entire kinome. learn more t.o.t® streamline the choice of therapeutic orientation for your projects by qualifying in vitro the potential of your molecules and your targets. learn more predict® select the best drug candidates and their biomarkers by harnessing our pharmacological expertise. learn more chi-mice® use our humanized models to reproduce the targeted pathology effectively: pdx, in vivo humanization of tissues from human stem cells (liver, immune system, skin, stroma, etc.). learn more pharmimage® integrate our multi-modal pharmaco-imaging expertise with your preclinical and clinical projects. learn more oncosnipe® set the direction at a very early stage for the research and development of therapeutic solutions for resistant and unresponsive patients. learn more oncodesign news [press release] oncodesign: 1st half 2018 results 26/09/2018 learn more [press release] precision medicine: cap digital and medicen paris-region team up with oncodesign, servier and intersystems on hu-precimed project 18/09/2018 learn more [congress] discovery on target – 25-28 september – boston - usa interested in next generation of kinase inhibitors, integrated drug discovery partner or services using our technological platforms? learn more [congress] europdx workshop - 1-3 october 2018 - weggis - switzerland join caroline mignard at the europdx workshop for great talks and discussions on all aspects of patient-derived xenograft tumor research! learn more see all news investors financial calendar stock price documentation press releases subscribe to the investor alert investors contacts word from the chairman since our april 2014 ipo, we have accelerated our development and have become an international biopharma company specialized in precision medicine pursuing ambitious development objectives underpinned by acquisition-led growth and investments in innovative therapeutic research programs. learn more careers oncodesign’s mission is to discover innovative new therapies effective against cancer and serious illnesses with unmet medical needs. oncodesign has opted to take the time to build up all the dimensions of its organization—scientific, technical, business, starting with the most crucial one, the human dimension . our values job offers/work-study arrangements internship available spontaneous applications contact us select a service (*) sales & marketing bu finance & shareholders relationship bu press relation bu administrative bu human resources bu invalid input (*) invalid input (*) invalid input (*) please write a subject for your message. (*) please let us know your message. send sales team if you have any questions, please contact the member of our sales team responsible for your geographical region, and we will get back to you as swiftly as we can. connect with us now about oncodesign vision our mission key figures management scientific advisory board where to find us offerings services partnerships licensing therapeutic areas & experimental models our innovation model etiology discovery experimentation our technologies nanocyclix® t.o.t.® predict® chi-mice® pharmimage® oncosnipe® investors a word from the chairman financial calendar shares documentation sign up for email alerts investors contacts carreers our values job offers/work-study arrangements internships spontaneous applications news upcoming events webinars scientific publications contact contact us sales team cookies legal notice contact us (c) copyright oncodesign - all right reserved 20 rue jean mazen | b.p. 27627 | 21076 dijon cedex | france | tel.+33 (0)3.80.78.82.60 | fax +33 (0)3.80.78.82.61 newsletter- en subscribe to the general newsletter (*) invalid input (*) invalid input sign-up subscribe to the investor alert by closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them. i agree! learn more

Analyse PopURL pour oncodesign.fr

https://www.oncodesign.fr/en/en/our-technologies/pharmimage-technology
https://www.oncodesign.fr/en/en/contact-us
https://www.oncodesign.fr/en/en/our-philosophy
https://www.oncodesign.fr/en/en/cookies-en
https://www.oncodesign.fr/en/#actualites
https://www.oncodesign.fr/en/en/our-innovation-model-en/etiology
https://www.oncodesign.fr/en/en/news-oncodesign/1124-precision-medicine-cap-digital-and-medicen-paris-region-team-up-with-oncodesign-servier-and-intersystems-on-hu-precimed-project
https://www.oncodesign.fr/en/en/about-oncodesign/management
https://www.oncodesign.fr/en/en/job-offers-alternance?id=228
https://www.oncodesign.fr/en/en/our-technologies/chi-mice-technology
https://www.oncodesign.fr/en/en/finance-contacts
https://www.oncodesign.fr/en/en/share-information/share-id
https://www.oncodesign.fr/en/en/documentation-en/press-releases/press-releases-2017
https://www.oncodesign.fr/en/en/about-oncodesign/scientific-advisory-board
https://www.oncodesign.fr/en/en/legal-notice
afssi.fr

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

%%
%% This is the AFNIC Whois server.
%%
%% complete date format : DD/MM/YYYY
%% short date format : DD/MM
%% version : FRNIC-2.5
%%
%% Rights restricted by copyright.
%% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%%
%% Use '-h' option to obtain more information about this service.
%%
%% [2600:3c03:0000:0000:f03c:91ff:feae:779d REQUEST] >> oncodesign.fr
%%
%% RL Net [#########.] - RL IP [#######...]
%%

domain: oncodesign.fr
status: ACTIVE
hold: NO
holder-c: O1789-FRNIC
admin-c: GC1786-FRNIC
tech-c: OH251-FRNIC
zone-c: NFC1-FRNIC
nsl-id: NSL1508-FRNIC
registrar: ORANGE
Expiry Date: 11/11/2017
created: 09/04/1999
last-update: 11/11/2016
source: FRNIC

ns-list: NSL1508-FRNIC
nserver: ns2.oleane.net
nserver: ns3.oleane.net
source: FRNIC

registrar: ORANGE
type: Isp Option 1
address: 78 Rue Olivier de Serres
address: 78-84
address: PARIS 15
country: FR
phone: +33 1 53 95 12 28
e-mail: domaine.admin@orange.com
website: http://www.hebergementweb.orange-business.com/noms-de-domaine/
anonymous: NO
registered: 15/02/2006
source: FRNIC

nic-hdl: GC1786-FRNIC
type: PERSON
contact: Genne Catherine
address: ONCODESIGN
address: parc Techn Toison d'Or
address: 28, rue de Broglie
address: 21000 Dijon
country: FR
phone: +33 3 80 78 82 60
fax-no: +33 3 80 78 82 61
e-mail: cgenne@oncodesign.fr
registrar: ORANGE
changed: 30/09/2004 syb@oleane.net
anonymous: NO
obsoleted: NO
source: FRNIC

nic-hdl: OH251-FRNIC
type: ROLE
contact: OLEANE Hostmaster
address: France Telecom
address: 13, rue de Javel
address: 75015 Paris
country: FR
phone: +33 1 53 95 14 00
fax-no: +33 1 53 95 14 01
e-mail: domaine-admin@list.orange-ftgroup.com
admin-c: CP460-FRNIC
tech-c: CW13-FRNIC
notify: hm-dbm-msgs@ripe.net
registrar: ORANGE
changed: 29/10/2004 hostmaster@oleane.net
anonymous: NO
obsoleted: NO
source: FRNIC

nic-hdl: O1789-FRNIC
type: ORGANIZATION
contact: ONCODESIGN
address: parc Techn Toison d'Or28, rue de Broglie
address: 21000 Dijon
country: FR
phone: +33 3 80 78 82 60
fax-no: +33 3 80 78 82 61
e-mail: it@oncodesign.com
registrar: ORANGE
changed: 24/08/2017 nic@nic.fr
anonymous: NO
obsoleted: NO
source: FRNIC


  REFERRER http://www.nic.fr

  REGISTRAR AFNIC

SERVERS

  SERVER fr.whois-servers.net

  ARGS oncodesign.fr

  PORT 43

  TYPE domain
RegrInfo
DISCLAIMER
%
% This is the AFNIC Whois server.
%
% complete date format : DD/MM/YYYY
% short date format : DD/MM
% version : FRNIC-2.5
%
% Rights restricted by copyright.
% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%
% Use '-h' option to obtain more information about this service.
%
% [2600:3c03:0000:0000:f03c:91ff:feae:779d REQUEST] >> oncodesign.fr
%
% RL Net [#########.] - RL IP [#######...]
%

  REGISTERED yes

ADMIN

  HANDLE GC1786-FRNIC

  TYPE PERSON

  CONTACT Genne Catherine

ADDRESS
ONCODESIGN
parc Techn Toison d'Or
28, rue de Broglie
21000 Dijon

  COUNTRY FR

  PHONE +33 3 80 78 82 60

  FAX +33 3 80 78 82 61

  EMAIL cgenne@oncodesign.fr

  SPONSOR ORANGE

  CHANGED 2004-09-30

  ANONYMOUS NO

  OBSOLETED NO

  SOURCE FRNIC

TECH

  HANDLE OH251-FRNIC

  TYPE ROLE

  CONTACT OLEANE Hostmaster

ADDRESS
France Telecom
13, rue de Javel
75015 Paris

  COUNTRY FR

  PHONE +33 1 53 95 14 00

  FAX +33 1 53 95 14 01

  EMAIL domaine-admin@list.orange-ftgroup.com

  ADMIN-C CP460-FRNIC

  TECH-C CW13-FRNIC

  NOTIFY hm-dbm-msgs@ripe.net

  SPONSOR ORANGE

  CHANGED 2004-10-29

  ANONYMOUS NO

  OBSOLETED NO

  SOURCE FRNIC

OWNER

  HANDLE O1789-FRNIC

  TYPE ORGANIZATION

  CONTACT ONCODESIGN

ADDRESS
parc Techn Toison d'Or28, rue de Broglie
21000 Dijon

  COUNTRY FR

  PHONE +33 3 80 78 82 60

  FAX +33 3 80 78 82 61

  EMAIL it@oncodesign.com

  SPONSOR ORANGE

  CHANGED 2017-08-24

  ANONYMOUS NO

  OBSOLETED NO

  SOURCE FRNIC

DOMAIN

  STATUS ACTIVE

  HOLD NO

  SPONSOR ORANGE

  EXPIRY DATE 11/11/2017

  CREATED 1999-04-09

  CHANGED 2016-11-11

  SOURCE FRNIC

  HANDLE NSL1508-FRNIC

NSERVER

  NS2.OLEANE.NET 194.2.0.2

  NS3.OLEANE.NET 194.250.249.14

  NAME oncodesign.fr

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.